Update on JAK Inhibitors

These unique drugs have advantages, but some caution is advised.


When it comes to treating inflammatory types of arthritis, including rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS), doctors have many drugs to choose from. They all work by targeting an underlying mechanism of these autoimmune diseases—specifically the action of the immune system that contributes to inflammation.

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access